Page last updated: 2024-08-25

methotrexate and Chronic Fatigue and Immune Dysfunction Syndrome

methotrexate has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fluge, Ø; Mella, O1
Poteliakhoff, A1

Other Studies

2 other study(ies) available for methotrexate and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.
    BMC neurology, 2009, Jul-01, Volume: 9

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Enzyme Inhibitors; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Rituximab; Young Adult

2009
Etanercept and methotrexate in rheumatoid arthritis.
    Lancet (London, England), 2004, May-22, Volume: 363, Issue:9422

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Fatigue Syndrome, Chronic; Humans; Immunoglobulin G; Methotrexate; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Stress, Psychological

2004